US Patent 8501704 Immunosuppression compound and treatment method
Patent 8501704 was granted and assigned to Sarepta Therapeutics on August, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 21 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08501704 Immunosuppression compound and treatment method US Patent 8501704 Immunosuppression compound and treatment method
Infobox
Patent Number
085017040
Patent Number
85017040
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
085017040
Date of Patent
August 6, 2013
0Patent Application Number
122674370
Date Filed
November 7, 2008
0Patent Primary Examiner
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08501704 Immunosuppression compound and treatment method
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08501704
Date of patent
August 6, 2013
Patent application number
12267437
Date Filed
November 7, 2008
Patent primary examiner
Find more entities like US Patent 8501704 Immunosuppression compound and treatment method
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.